SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance

U.S. Markets closed

Sanofi (SNY)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
47.30+0.39 (+0.83%)
At close: 4:02PM EDT

47.45 0.15 (0.32%)
After hours: 4:34PM EDT

People also watch
NVSGSKAZNLLYNVO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close46.91
Open47.50
Bid0.00 x
Ask0.00 x
Day's Range46.90 - 47.52
52 Week Range36.81 - 47.52
Volume2,167,513
Avg. Volume1,493,435
Market Cap116.61B
Beta0.75
PE Ratio (TTM)24.31
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.58 (3.40%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Regeneron (REGN) to Post Q1 Earnings: What's in the Cards?
    Zacks5 hours ago

    Regeneron (REGN) to Post Q1 Earnings: What's in the Cards?

    Regeneron Pharmaceuticals, Inc. (REGN) is scheduled to release first-quarter 2017 results on May 4, before the opening bell.

  • The Wall Street Journal11 hours ago

    [$$] Sanofi 1Q Net Profit Rises on Sale of Animal-Health Unit

    French drugmaker Sanofi said 1Q net profit jumped to about $6.2 billion, boosted by the sale of its animal-health business. To revive growth, Sanofi has boosted its research and is seeking to acquire an ...

  • American City Business Journals12 hours ago

    ​Sarepta shares jump as CEO’s planned exit spurs takeover speculation

    Shares of Sarepta Therapeutics soared Friday morning amid speculation that the planned departure of CEO Ed Kaye makes the Cambridge biotech a prime takeover target. Kaye made the surprise announcement on a conference call with analysts Thursday, saying that he will step down from his role as CEO of Sarepta (SRPT) by the end of the year, but will remain on the company’s board. Meanwhile, TheStreet’s Adam Feuerstein speculated Friday that Sanofi (SNY) could emerge as a suitor.